SIR,-Dr Paul Belchetz's editorial' presents an oversimplistic and overoptimistic assessment of the risks, benefits, and acceptability of currently offered hormone replacement treatment.
I agree that there is evidence that oestrogen treatment protects against cardiovascular and cerebrovascular disease in postmenopausal women, but I am not so confident that the evidence is abundant and leaves no room for doubt. I also agree that doctors remain suspicious about climactic oestrogen treatment because they "wrongly extrapolate from the experience of younger women who take oral contraceptives." Unfortunately, Dr Belchetz does not explain why the extrapolation is wrong. It is because oral contraceptives contain progestogens. The protective effect of oestrogens against vascular disease has been measured almost exclusively in women who have not taken progestogens. The benefits may well be substantial. Henderson et al estimated that women aged between 50 and 75 who had taken a moderate dose of oestrogen (equivalent to 0 625 mg of conjugated oestrogens daily) would show a reduction in 25 year mortality from ischaemic heart disease alone of 5250 per 100000 women whereas the comparable increased mortality from endometrial cancer would be only 63 per 100 000. 2 Progestogens generally cause changes in lipid and carbohydrate metabolism that are associated with increased risks of atheroma. Among others we have shown that the risks of arterial disease in users of oral contraceptives are associated with the progestogen component in combined oral contraceptives.3 What happens then if progestogen is added to the oestrogen treatment in climacteric women? The simple and honest answer is that we don't know. There may be no adverse effects, but we have no scientific justification for this assumption. If an adverse response was no greater than to neutralise the benefits of unopposed oestrogen in arterial disease it would still be the wrong treatment. At worst, if the addition of progestogens was to increase the occurrence of ischaemic heart disease and stroke in postmenopausal women above that in untreated women the outcome might be disastrous.
In. 1977 this unit conducted a pilot study of the clinical course in women receiving hormone replacement treatment with a design similar to that of our oral contraception study, which has been in progress since 1968. The methods used in the pilot study were entirely successful, but prescribing of hormone replacement treatment by general practitioners at that time was impracticably low. Now that the rate of prescribing has doubled updated proposals for a study are being prepared; unfortunately, its chance of funding is much lower than it would have been 10 years ago.
The objective of the study is to measure the balance of risk between potential beneficial and adverse effects of treatment on many different diseases-cancers, vascular disease, osteoporosis, and perhaps other unsuspected outcomes. These can be appropriately assessed only in the course of a cohort study in which the incidences of these diseases are measured directly. The issues are so important that reliance on a single study would be foolish, and at least two independent investigations should be started soon. CLIFFORD Profile of the GMC SIR,-Doctors are acknowledged masters of the delicate expression of uncertainty and I have, till now, illustrated their mastery with a footnote from the Lancet: "Since this paper was written, one of us has died." I can now replace that aging gem with a quotation from your leading letter of 17 June, in which five doctors of irrefutable distinction write: "We fully acknowledge that Dr Richard Smith's articles about the General Medical Council have been written after wide consultation with members and staff of the council, other interested persons, and at least one of us."' (The italics, of course, are mine.) That "at least" is dangerous fuel for an irreverent imagination. Is it the pressure of busy lives or, perish the thought, failing powers of memory that make it difficult for them to recall whether the good doctor consulted more than one? Or are they indulging in an extreme form of professional anonymity, pour encourager .? Or could it be that "one of us" is being used as the generic phrase so favoured by the Prime Minister? Or is the whole thing just a sophisticated guessing game with discreet off course bets being laid in the corridors of power? I suppose we should be grateful that, in these days of excessive fragmentation, no less than one was consulted.
Meanwhile Dr Richard Smith deserves congratulations for a series of articles which give a clear account of the way the GMC operates-no easy task, as many members of the council will acknowledge -and for his fair minded presentation of arguments that have gone on in and around the council for more years than I care to remember. Self regulation is vitally important if we are not to have regulation imposed on us by the government. But the present situation, with doctors being judged by individuals who have little knowledge of the working environment of the practitioner concerned, is grossly unfair. I hope that the same system is not applied to the recent proposals.
Re-education of practitioners who are not clinically competent seems a sensible idea, but I believe that this could best be undertaken by the postgraduate dean, in association with the regional adviser, making use of an experienced and competent trainer. Medical education as a whole needs to be centred closer to the community, rather than becoming increasingly remote.
With so many far reaching issues facing the profession it is vitally important that the GMC's composition reflects more closely the structure of the profession as a whole. If the GMC is not to remain stuffed with academics and professional committee men each and every general practitioner must make it his or her personal responsibility to make sure that his or her voice is heard and vote counted.
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Ethnic differences in incidence of severe burns and scalds SIR, -Dr V Vipulendran and colleagues suggested that burns and scalds are more common in Asian than non-Asian children in Birmingham,' but their analysis ignores several possible confounding factors that might explain this statistical finding.
Although recognising that most of the children BMJ VOLUME 299 First myocardial infarction in Asian and white men SIR, -Dr L 0 Hughes and colleagues consider that an increased incidence of diabetes may not be relevant to the greater propensity to coronary atheroma in Asians. ' We have shown in Leicester that people of Asian origin have a significantly higher relative risk (about 2) of developing non-insulin dependent diabetes than white people and that this persists in all ages over 16 years. I We subsequently performed parallel case referent studies in these two ethnic groups, calculating for each the relative risk of acute myocardial infarction associated with diabetes. The cases were 493 consecutive patients aged 45 or above admitted to the coronary care unit with a proved myocardial infarction (50 Asian, 443 white). The referent population consisted of 17 865 people (6949 Asian, 10916 white) aged 45 years or above from the population in which the cases arose. Overall estimates of relative risk were derived using precision based weights, and 95% confidence intervals were calculated by Miettinen's test based method.
There was a highly significant association between diabetes and acute myocardial infarction
between age and diabetes as determinants of risk. ' Recent research has suggested possible interactions between microalbuminuria or hyperinsulinaemia (which may reflect increased insulin resistance) in the association between noninsulin dependent diabetes and ischaemic heart disease. We have shown a greater prevalence of proteinuria in Asian diabetics4 and that their first degree relatives have a greater degree of insulin resistance before the onset of clinical diabetes than their white counterparts. 4 We therefore think that diabetes mellitus is an important risk factor in the development of coronary artery disease in Asians. Plasma cholesterol, coronary heart disease, and cancer SIR,-The positive relation between cholesterol and coronary heart disease and the inverse relation between cholesterol and cancer, noted in the Renfrew-Paisley survey,' and the negative relation between cholesterol concentration and cancer in China2 indicate that a biological variable may have noxious associations with disease in one ethnic group but be less noxious in another. Our rural African blacks resemble the Chinese: low cholesterol values (mean about 4 mmol/l), less than half the incidence of cancer, especially diet related cancers, and coronary heart disease virtually absent.' In contrast, local Indians, with cholesterol values and cancer incidences intermediate between those of the black and white populations, have the highest mortality from coronary heart disease4; indeed, wherever Indians migrate their rates tend to become higher than those of the host populations.' Remarkably, in one report from India the cholesterol concentrations of three quarters of a group of patients with myocardial infarction were less than 4 mmol/l.6 Thus, a given cholesterol concentration can be much more pathognomonic of coronary heart disease in one population than in another.
This type of situation also holds to a certain extent for obesity and hypertension. Severe obesity (body mass index >30) is conducive to hypertension, hyperlipidaemia, and hyperglycaemia in white adults but less so in black adults. In studies on obese black women we have found little association with the sequelae mentioned7; actually, over three quarters showed "healthy" obesity, among whom weight reduction is not mandatory.' Interestingly, in the United States obesity in blacks is still less promotive of hypertension than it is in whites.' In rural African blacks the prevalence of hypertension is low (a generation ago hypertension was rare); but in big cities its prevalence now exceeds that in whites."' Yet this is consistent with coronary heart disease remaining uncommon.
In other words, both severe obesity and severe hypertension evoke less damage in blacks than would be expected.
There are environmental and metabolic factors which inhibit, and factors which promote or aggravate, disorders and diseases. Yet the identities of many of these factors are unknown. Because of their operation there are numerous puzzling epidemiological occurrences. Thus, in Sydney, Australia, there are threefold differences in colorectal cancer mortality in adjacent districts." Similar inexplicable situations with cancer prevail in Scotland.'2 Doubtless many unknown factors have contributed to the recent major falls in the incidence of coronary heart disease, stroke, gastric cancer, appendicitis, and dental caries in developed populations. These changes make research in epidemiology so challenging and exciting. Positive end expiratory pressure and oxygen delivery SIR,-The conclusion of Drs Mervyn Singer and David Bennett that their results highlight the need to monitor circulatory changes' is a good argument for increasing pulmonary artery catheterisation rather than for "comparatively non-invasive" techniques.
In critically ill patients analysis of mixed venous blood gas tensions to determine oxygen tension and saturation has been stated as the cornerstone of assessment of global oxygen transport,2 and adequately mixed blood samples for determining these values can be obtained only from the right ventricular outflow tract or pulmonary artery with a flow directed catheter. Measurements of mixed venous oxygen content and of arterial oxygen content and cardiac output permit calculation of whole body oxygen consumption. All of these values have prognostic and therapeutic importance,' and minimal optimal goals for them have been suggested.4 Drs Singer and Bennett did not mention absolute values for cardiac output or oxygen delivery so that a comparison with the accepted optimal values for resuscitation cannot be made.
